Is anyone doing HLA sequencing with the Nimblgene SeqCap EZ Human MHC design? Or are you doing HLA with your own custom pull-down kit? If so, I would really like to talk to you. I'm at a startup building a sequencing sample prep/analysis technology that will (among other things) significantly increase the performance of HLA sequencing, and we are looking for potential collaborators in this area.
-
-
Hello mschnall,
Our lab has sequenced ~500 samples using NimbleGen's MHC design. For the most part, the sequencing worked quite well. Because of the high heterogeneity of several of the genes in this region (DQA1, DQB1, HLA-A, ect.), you will will have problems aligning reads to a single consensus sequence (hg19). Our bioinformatics core is currently helping us to resolve this problem.
DoubleA -
thanks a lot for the reply, doubleA. we are building a new technology that should help significantly with some of the alignment ambiguities as well as providing phasing information. if you think you might be interested in trying out our technology in the coming months, send me a private message and i can give you more details.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment